YatırımMasasıYatırım Masası home
AstraZeneca Faces $16.0 Billion Revenue Test on October 30
AstraZeneca, which posted earnings per share of $1.31 against expectations of $1.25 in the previous quarter, will announce its financial results for the period ended September 30.
AZNAstraZeneca (AZN), traded on the US market, will announce its financial results for the quarter ended September 30 on Friday, October 30, 2026. Revenue expectations for the company in this period stand at $16.0 billion. In the previous quarter, AstraZeneca posted earnings per share of $1.31 against expectations of $1.25.
The average move in AstraZeneca shares over the past 4 earnings days was 3.7%. Looking at the company's past earnings reactions: an upward move of 1.7% in July, 3.0% upward in July of last year, and a 2.9% upward move in February of last year were recorded. In the November 2024 earnings, however, the stock had retreated 7.2% downward.
This content is for information purposes only and does not constitute investment advice.
This article is a translation of the original Turkish version published by Yatırım Masası. Read the original in Turkish
Prepared by the Yatırım Masası newsroom from current market developments and official data.
This is not investment advice. The data and commentary in this article are for information only; make investment decisions based on your own research and, where needed, advice from a licensed professional.